Private Advisor Group LLC lifted its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 2.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,279 shares of the company’s stock after acquiring an additional 834 shares during the quarter. Private Advisor Group LLC’s holdings in Clorox were worth $5,242,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Catalyst Capital Advisors LLC acquired a new position in shares of Clorox during the third quarter valued at approximately $54,000. Los Angeles Capital Management LLC increased its stake in shares of Clorox by 5.6% during the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after acquiring an additional 10,149 shares during the period. Advisors Asset Management Inc. increased its stake in shares of Clorox by 43.4% during the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after acquiring an additional 9,037 shares during the period. Natixis Advisors LLC grew its position in Clorox by 8.3% in the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after buying an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after buying an additional 13,038 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth
CLX has been the topic of several recent research reports. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. JPMorgan Chase & Co. lifted their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Wells Fargo & Company lifted their price target on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Barclays lifted their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $158.21.
Clorox Trading Up 2.8 %
NYSE CLX opened at $157.41 on Friday. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market cap of $19.39 billion, a price-to-earnings ratio of 43.01, a PEG ratio of 2.62 and a beta of 0.42. The firm’s 50 day moving average price is $157.72 and its two-hundred day moving average price is $159.73.
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the company posted $2.16 earnings per share. Equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- The 3 Best Fintech Stocks to Buy Now
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Why Invest in High-Yield Dividend Stocks?
- DuPont’s Electronics Spinoff: The Start of Something Big
- What is the Australian Securities Exchange (ASX)
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.